Effect of Stromal Cell-Derived Factor 1α Bio-Functionalization on Tissue Formation of Vascular In Situ Tissue Engineered Grafts in Rats With CKD

被引:0
|
作者
Krebber, Merle M. [1 ]
Besseling, Paul J. [1 ]
Fledderus, Joost O. [1 ]
Dankers, Patricia Y. [2 ]
Bouten, Carlijn V. [2 ]
Verhaar, Marianne C. [1 ]
机构
[1] Univ Med Ctr Utrecht, Utrecht, Netherlands
[2] Tech Univ Eindhoven, Eindhoven, Netherlands
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
FR-PO383
引用
收藏
页码:427 / 427
页数:1
相关论文
共 50 条
  • [1] CHRONIC KIDNEY DISEASE NOR STROMAL CELL-DERIVED FACTOR 1A PEPTIDE (SDF-1A) BIO-FUNCTIONALIZATION ALTER RODENT VASCULAR IN SITU TISSUE FORMATION
    Krebber, Merle
    Bessseling, Paul
    Driessen, Rob
    Sontjens, Serge
    Janssen, Henk
    Teraa, Martin
    Fledderus, Joost
    Dankers, Patricia
    Bouten, Carlijn
    Verhaar, Marianne
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I151 - I151
  • [2] Delivery of stromal cell-derived factor 1α for in situ tissue regeneration
    Zhao, Wen
    Jin, Kaixiang
    Li, Jiaojiao
    Qiu, Xuefeng
    Li, Song
    JOURNAL OF BIOLOGICAL ENGINEERING, 2017, 11
  • [3] Delivery of stromal cell-derived factor 1α for in situ tissue regeneration
    Wen Zhao
    Kaixiang Jin
    Jiaojiao Li
    Xuefeng Qiu
    Song Li
    Journal of Biological Engineering, 11
  • [4] The effect of chronic kidney disease on tissue formation of in situ tissue-engineered vascular grafts
    Besseling, Paul J. J.
    Krebber, Merle M. M.
    Fledderus, Joost O. O.
    Teraa, Martin
    den Ouden, Krista
    van de Kaa, Melanie
    de Bree, Petra M. M.
    Serrero, Aurelie
    Bouten, Carlijn V. C.
    Dankers, Patricia Y. W.
    Cox, Martijn A. J.
    Verhaar, Marianne C. C.
    APL BIOENGINEERING, 2023, 7 (02)
  • [5] Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells
    Wang, Lunchang
    Hu, Jiang
    Sorek, Claire E.
    Chen, Eugene Y.
    Ma, Peter X.
    Yang, Bo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (03) : 317 - 330
  • [6] Balancing Scaffold Degradation and Neo-Tissue Formation in In Situ Tissue Engineered Vascular Grafts
    Uiterwijk, Marcelle
    Coolen, Bram F.
    van Rijswijk, Jan-Willem
    Soentjens, Serge H. M.
    van Houtem, Michel H. C. J.
    Szymczyk, Wojciech
    Rijns, Laura
    Janssen, Henk M.
    van de Wal, Allard
    de Mol, Bas A. J. M.
    Bouten, Carlijn V. C.
    Strijkers, Gustav J.
    Dankers, Patricia Y. W.
    Kluin, Jolanda
    TISSUE ENGINEERING PART A, 2024, 30 (15-16) : 421 - 436
  • [7] Structure and function of engineered stromal cell-derived factor-1α
    Son, Gitae
    Seon, Gyeung Mi
    Choi, Sang Hoon
    Yang, Hyeong-Cheol
    DENTAL MATERIALS JOURNAL, 2024, 43 (02) : 286 - 293
  • [8] In Situ Blood Vessel Regeneration Using SP (Substance P) and SDF (Stromal Cell-Derived Factor)-1 Peptide Eluting Vascular Grafts
    Shafiq, Muhammad
    Zhang, Qiuying
    Zhi, Dengke
    Wang, Kai
    Kong, Deling
    Kim, Dong-Hwee
    Kim, Soo Hyun
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (07) : E117 - E134
  • [9] The role of myeloid cell-derived PDGF-B in neotissue formation in a tissue-engineered vascular graft
    Onwuka, Ekene
    Best, Cameron
    Sawyer, Andrew
    Yi, Tai
    Heuer, Eric
    Sams, Malik
    Wiet, Matthew
    Zheng, Hong
    Kyriakides, Themis
    Breuer, Christopher
    REGENERATIVE MEDICINE, 2017, 12 (03) : 249 - 261
  • [10] Human iPS Cell-derived Tissue Engineered Vascular Graft: Recent Advances and Future Directions
    Shi, Xiangyu
    He, Lile
    Zhang, Shang-Min
    Luo, Jiesi
    STEM CELL REVIEWS AND REPORTS, 2021, 17 (03) : 862 - 877